Association between the systemic immune‐inflammation index and erectile dysfunction: A cross‐sectional study
Immunity, Inflammation and Disease · 2024-08 · 12 (8)
DOI: 10.1002/iid3.1363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 02.08.2024. Verfasst von Di Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Urology, Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. Hauptthemen laut MEDLINE: Erectile Dysfunction, Inflammation, Nutrition Surveys. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Erectile dysfunction (ED) is associated with inflammation. The systematic immune‐inflammation index (SII), as a new inflammation marker, was applied to predict the risk of diseases. However, no research explores the relationship between SII and ED. Hence, the purpose of this study was to investigate the association between SII and ED.
Methods
Related data were obtained from the National Health and Nutrition Examination Survey (NHANES) 2001−2004. Based on self‐report, all participants were classified into ED and non‐ED group. Weighted multivariate regression analysis the relationship between categorical SII and ED in unadjusted and adjusted models. Restricted cubic spline (RCS) was used to examine the association of continuous SII and ED risk. Furthermore, the association between categorical SII and the risk of ED was evaluated among subgroups of age, body mass index, hypertension, diabetes and cardiovascular disease. Finally, weighted multivariate regression analysis and RCS were performed to assessed the connection between SII and the risk of severe ED.
Results
Initially, data on 21,161 participants were obtained. After implementing the inclusion and exclusion criteria, 3436 participants were included in analyses. Weighted multivariate regression analysis demonstrated that Q4 group SII was associated with an increased risk of ED (OR = 1.03, 95% confidence intervals: 1.00−1.05, p = .03). RCS showed SII was nonlinearly associated with the risk of ED, and the inflection point of SII was at 485.530. In addition, subgroup analyses demonstrated that participants in the SII > 485.530 group had a higher ED risk than SII ≤ 485.530 group among subgroups of age ≥50, hypertension, and non‐diabetes. Weighted multivariate regression analysis and RCS found no relationship of SII and the risk of severe ED.
Conclusion
In US adults, SII > 485.530 was correlated with an increased risk of ED. While, no significant association between SII and severe ED risk. Additional studies are required to support our results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Department of Urology, Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Graduate School, Guangxi Medical University, Nanning, China.
- The Second Department of Urology, The First People's Hospital of Qinzhou City, Qinzhou, China.
- The Department of Urology, The Second People's Hospital of Nanning City, Nanning, China.
- The Department of Urology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
ORCID-Profile: Gang Liu
Zitieren
APA
Chen, D., Chen, F., Luo, Q., Fan, W., Chen, C., & Liu, G. (2024). Association between the systemic immune‐inflammation index and erectile dysfunction: A cross‐sectional study. Immunity, Inflammation and Disease, 12(8). https://doi.org/10.1002/iid3.1363
Vancouver
Chen D, Chen F, Luo Q, Fan W, Chen C, Liu G. Association between the systemic immune‐inflammation index and erectile dysfunction: A cross‐sectional study. Immunity, Inflammation and Disease. 2024;12(8). doi:10.1002/iid3.1363
BibTeX
@article{Chen2024,
author = {Chen, Di and Chen, Fuchang and Luo, Quanhai and Fan, Wenji and Chen, Changsheng and Liu, Gang},
title = {Association between the systemic immune‐inflammation index and erectile dysfunction: A cross‐sectional study},
journal = {Immunity, Inflammation and Disease},
year = {2024},
volume = {12},
number = {8},
doi = {10.1002/iid3.1363}
}
EUVIMED